Search

Your search keyword '"Koustenis, Andrew"' showing total 11 results
Start Over Author "Koustenis, Andrew" Publisher american association for cancer research (aacr)
11 results on '"Koustenis, Andrew"'

1. Supplemental Table from MONARCH 1, A Phase II Study of Abemaciclib, a CDK4 and CDK6 Inhibitor, as a Single Agent, in Patients with Refractory HR+/HER2− Metastatic Breast Cancer

Author

Dickler, Maura N., primary, Tolaney, Sara M., primary, Rugo, Hope S., primary, Cortés, Javier, primary, Diéras, Véronique, primary, Patt, Debra, primary, Wildiers, Hans, primary, Hudis, Clifford A., primary, O'Shaughnessy, Joyce, primary, Zamora, Esther, primary, Yardley, Denise A., primary, Frenzel, Martin, primary, Koustenis, Andrew, primary, and Baselga, José, primary

Published
2023
Full Text
View/download PDF

2. Supplemental Figures from MONARCH 1, A Phase II Study of Abemaciclib, a CDK4 and CDK6 Inhibitor, as a Single Agent, in Patients with Refractory HR+/HER2− Metastatic Breast Cancer

Author

Dickler, Maura N., primary, Tolaney, Sara M., primary, Rugo, Hope S., primary, Cortés, Javier, primary, Diéras, Véronique, primary, Patt, Debra, primary, Wildiers, Hans, primary, Hudis, Clifford A., primary, O'Shaughnessy, Joyce, primary, Zamora, Esther, primary, Yardley, Denise A., primary, Frenzel, Martin, primary, Koustenis, Andrew, primary, and Baselga, José, primary

Published
2023
Full Text
View/download PDF

3. Supplemental Methods from MONARCH 1, A Phase II Study of Abemaciclib, a CDK4 and CDK6 Inhibitor, as a Single Agent, in Patients with Refractory HR+/HER2− Metastatic Breast Cancer

Author

Dickler, Maura N., primary, Tolaney, Sara M., primary, Rugo, Hope S., primary, Cortés, Javier, primary, Diéras, Véronique, primary, Patt, Debra, primary, Wildiers, Hans, primary, Hudis, Clifford A., primary, O'Shaughnessy, Joyce, primary, Zamora, Esther, primary, Yardley, Denise A., primary, Frenzel, Martin, primary, Koustenis, Andrew, primary, and Baselga, José, primary

Published
2023
Full Text
View/download PDF

4. Supplemental Table from MONARCH 1, A Phase II Study of Abemaciclib, a CDK4 and CDK6 Inhibitor, as a Single Agent, in Patients with Refractory HR+/HER2− Metastatic Breast Cancer

Author

Dickler, Maura N., primary, Tolaney, Sara M., primary, Rugo, Hope S., primary, Cortés, Javier, primary, Diéras, Véronique, primary, Patt, Debra, primary, Wildiers, Hans, primary, Hudis, Clifford A., primary, O'Shaughnessy, Joyce, primary, Zamora, Esther, primary, Yardley, Denise A., primary, Frenzel, Martin, primary, Koustenis, Andrew, primary, and Baselga, José, primary

Published
2023
Full Text
View/download PDF

5. Supplemental Methods from MONARCH 1, A Phase II Study of Abemaciclib, a CDK4 and CDK6 Inhibitor, as a Single Agent, in Patients with Refractory HR+/HER2− Metastatic Breast Cancer

Author

Dickler, Maura N., primary, Tolaney, Sara M., primary, Rugo, Hope S., primary, Cortés, Javier, primary, Diéras, Véronique, primary, Patt, Debra, primary, Wildiers, Hans, primary, Hudis, Clifford A., primary, O'Shaughnessy, Joyce, primary, Zamora, Esther, primary, Yardley, Denise A., primary, Frenzel, Martin, primary, Koustenis, Andrew, primary, and Baselga, José, primary

Published
2023
Full Text
View/download PDF

6. Supplemental Figures from MONARCH 1, A Phase II Study of Abemaciclib, a CDK4 and CDK6 Inhibitor, as a Single Agent, in Patients with Refractory HR+/HER2− Metastatic Breast Cancer

Author

Dickler, Maura N., primary, Tolaney, Sara M., primary, Rugo, Hope S., primary, Cortés, Javier, primary, Diéras, Véronique, primary, Patt, Debra, primary, Wildiers, Hans, primary, Hudis, Clifford A., primary, O'Shaughnessy, Joyce, primary, Zamora, Esther, primary, Yardley, Denise A., primary, Frenzel, Martin, primary, Koustenis, Andrew, primary, and Baselga, José, primary

Published
2023
Full Text
View/download PDF

8. Abstract P046: ENGOT-ov60/GOG3052/RAMP 201: A phase 2 study of VS-6766 (dual RAF/MEK inhibitor) alone and in combination with defactinib (FAK inhibitor) in recurrent low-grade serous ovarian cancer (LGSOC)

Author

Banerjee, Susana N., primary, Monk, Bradley J., additional, Van Nieuwenhuysen, Els, additional, Moore, Kathleen N., additional, Oaknin, Ana, additional, Fabbro, Michel, additional, Columbo, Nicoletta, additional, O’Malley, David M., additional, Coleman, Robert L., additional, Pachter, Jonathan, additional, Koustenis, Andrew, additional, Patrick, Gloria, additional, Leonard, Lorna, additional, and Grisham, Rachel, additional

Published
2021
Full Text
View/download PDF

10. MONARCH 1, A Phase II Study of Abemaciclib, a CDK4 and CDK6 Inhibitor, as a Single Agent, in Patients with Refractory HR+/HER2− Metastatic Breast Cancer

Author

Dickler, Maura N., primary, Tolaney, Sara M., additional, Rugo, Hope S., additional, Cortés, Javier, additional, Diéras, Véronique, additional, Patt, Debra, additional, Wildiers, Hans, additional, Hudis, Clifford A., additional, O'Shaughnessy, Joyce, additional, Zamora, Esther, additional, Yardley, Denise A., additional, Frenzel, Martin, additional, Koustenis, Andrew, additional, and Baselga, José, additional

Published
2017
Full Text
View/download PDF

11. Abstract CT044: MONARCH 1: Final overall survival analysis of a phase 2 study of abemaciclib, a CDK4 and CDK6 inhibitor, as monotherapy, in patients with HR+/HER2- breast cancer, after chemotherapy for advanced disease

Author

Rugo, Hope S., primary, Tolaney, Sara M., additional, Cortés, Javier, additional, Diéras, Véronique, additional, Patt, Debra A., additional, Wildiers, Hans, additional, Nanda, Shivani, additional, Koustenis, Andrew G., additional, Dickler, Maura N., additional, and Baselga, José, additional

Published
2017
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results